Prophylaxis by doravirine-lamivudine-tenofovir disoproxil fumarate or elvitegravir-cobicistat-emtricitabine-tenofovir alafenamide after sexual exposure to HIV

Prophylaxis by doravirine-lamivudine-tenofovir disoproxil fumarate or elvitegravir-cobicistat-emtricitabine-tenofovir alafenamide after sexual exposure to HIV

Abstract HIV post- exposure prophylaxis (PEP) is a prevention tool for individuals with a recent potential exposure to HIV. Doravirine has been available since 2019 in combination with tenofovir disoproxil fumarate and lamivudine and has not been evaluated as a PEP. DOR/3TC/TDF is our department’s m...

Full description

Bibliographic Details
Main Authors: Inès Devred, Kick Kayembe, Nadia Valin, Hayette Rougier, Bruce Wuembulua Shinga, Sidonie Lambert-Niclot, Thibault Chiarabini, Marie-Caroline Meyohas, Karine Lacombe
Format: Article
Language:English
Published: BMC 2023-09-01
Series:BMC Infectious Diseases
Subjects:
Post-exposure prophylaxis
Doravirine
HIV
Adherence
Completion rate
Online Access:https://doi.org/10.1186/s12879-023-08544-x

Internet

https://doi.org/10.1186/s12879-023-08544-x

Similar Items